News

14th Oct 2020

The New Drug Evaluation for oral semaglutide (Rybelsus) for the treatment of type 2 diabetes mellitus is now available to stakeholders.

14th Oct 2020
Our October 2020 Monthly Horizon Scanning Report is now available.
  
13th Oct 2020

Updates to our Items not to be routinely prescribed (INRP) report with 20202021 Q1 data are now available online.

12th Oct 2020

The antibacterial drugs report for April to June 2020 is now available.

9th Oct 2020

The New Drug Evaluation for Brolucizumab for the treatment of wet age-related macular degeneration is now available to stakeholders.

8th Oct 2020

The latest NCSO bulletin based on September 2020 prices is now available online for stakeholders only.

7th Oct 2020

The RDTC has updated the COVID-19 QAAs No.7 (Electronic repeat dispensing advice ), and No.

5th Oct 2020

Updates to our Cardiovascular, Dementia, Diabetes and Respiratory reports with 2020/2021 Q1 data are now available online.

1st Oct 2020

The RDTC has updated COVID-19 QAA No 13 (Anticoagulation in cancer) with minor changes to the weblinks.

29th Sep 2020

The RDTC has updated the COVID-19 QAAs No.5 (Prescribing in diabetes guidance), and No.

Pages

Subscribe to News